Product Images Budesonide Inhalation
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Budesonide Inhalation NDC 68788-8503 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description for a medication called Budesonide Inhalation Suspension. The medication is available in a 0.5mg/2mL single-dose ampule. The generic name for this medication is Pulmicort. It is manufactured by Lupin Pharmaceuticals, Inc. It should be stored upright at a temperature between 20° to 25°C (68" to 77°F). The medication should not be frozen and should be protected from light. Once opened, the contents of the ampule should be used immediately. The medication is for inhalation only and should be used as directed by a physician. The description also includes instructions in both English and Spanish.*
Nighttime Asthma Change from Baseline was evaluated. The mean change from Baseline for nighttime Asthma Symptoms was measured. The data was collected over a period of 12 weeks. Different dosage levels were administered, including 0.25 mg, 0.5 mg, and 1.0 mg once daily. The p-values for these dosage levels were calculated to be 0.001, 0.010, and 0.009 respectively.*
Nighttime Asthma Change from Baseline: The given text provides information about the mean change from baseline in nighttime asthma symptoms. The values obtained for the change from baseline are 0.1 and 0.0. The data also includes the p-values for different medication dosages: 0.25 mg (p-value: 0.022) and 0.5 mg (p-value: 0.021). However, the information provided is not sufficient to determine the context or significance of these values.*
Nighttime Asthma Change from Baseline is a study evaluating the mean change in nighttime asthma symptoms from baseline. The study includes different treatment groups receiving varying dosages of a medication. The placebo group and multiple dosage groups are compared over a period of 12 weeks. The p-values for each dosage group are provided, indicating the statistical significance of the observed changes in symptoms.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.